Galapagos | Creditori Commerciali



Trade Creditors Cambiamento Data
AstraZeneca 22.54B 79M 2025-03
Biogen USD 391.5M 32.7M 2025-03
Gilead Sciences USD 833M 70M 2024-12
GlaxoSmithKline 15.15B 186M 2025-03
GRIFOLS EUR 852.3M 25.42M 2024-12
Hikma Pharmaceutical USD 541M 232M 2024-06
Incyte USD 195.54M 1.93M 2025-03
Merck EUR 1.5B 448M 2024-12
Neurocrine Biosciences 110M 282.7M 2024-12
Novartis USD 4.57B 485M 2024-12
Roche Holding 4.35B 828M 2024-12
Sanofi 21.62B 14.07B 2025-03
UCB 750M 1.66B 2024-12
Vertex Pharmaceuticals USD 413M 17.2M 2024-12



Galapagos Creditori Commerciali - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.